The success of Sildenafil initially fueled a period of growth for major pharmaceutical companies, however recent developments present a uncertain scenario for shareholders. Off-patent versions are eroding revenue, and https://lawsonjuaz480087.like-blogs.com/41032336/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment